Veracyte Current Deferred Revenue (Quarterly) Insights

Veracyte, Inc. (VCYT)

42.10 -0.18 (-0.43%) USD | NASDAQ | Dec 31, 16:00

41.75 -0.35 (-0.83%) After-Hours: 20:00

View Current Deferred Revenue (Quarterly) for VCYT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Thermo Fisher Scientific, Inc.	Upgrade
FONAR Corp.	Upgrade
XWELL, Inc.	Upgrade
ProPhase Labs, Inc.	Upgrade
Insight Molecular Diagnostics, Inc.	--